Gut microbiota impact on stroke outcome: Fad or fact?

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 5, 2015, Pages 891-898

  Winek, Katarzyna ^a   Meisel, Andreas ^a   Dirnagl, Ulrich ^a,b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Brain ischemia; brain trauma; immunology; physiology; regeneration and recovery

Indexed keywords

ATHEROSCLEROSIS; BLOOD SAMPLING; CEREBROVASCULAR ACCIDENT; COMMENSAL; COMPARATIVE STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA EXTRACTION; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; METAGENOMICS; MICROBIAL COMMUNITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; ANIMAL; BLOOD BRAIN BARRIER; GASTROINTESTINAL TRACT; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; STROKE;

EID: 84964969214     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16636890     Document Type: Review

References (102)

1. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214.
2. Xu MQ, Cao HL, Wang WQ, et al. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 2015; 21: 102-111.
3. Hanage WP. Microbiology: Microbiome science needs a healthy dose of scepticism. Nature 2014; 512: 247-248.
4. Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694-1697.
5. Lepage P, Leclerc MC, Joossens M, et al. A metagenomic insight into our gut's microbiome. Gut 2013; 62: 146-158.
6. O'Hara AM and Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-693.
7. Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904.
8. Collins SM, Surette M and Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-742.
9. Neunlist M, Van Landeghem L, Mahe MM, et al. The digestive neuronal-glial-epithelial unit: A new actor in gut health and disease. Nat Rev Gastroenterol Hepatol 2013; 10: 90-100.
10. Furness JB. The enteric nervous system and neurogas-troenterology. Nat Rev Gastroenterol Hepatol 2012; 9: 286-294.
11. Matteoli G and Boeckxstaens GE. The vagal innervation of the gut and immune homeostasis. Gut 2013; 62: 1214-1222.
12. Barrett E, Ross RP, O'Toole PW, et al. Gamma-amino-butyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113: 411-417.
13. Lyte M. Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol 2004; 12: 14-20.
14. Freestone P. Communication between bacteria and their hosts. Scientifica (Cairo) 2013; 2013: 361073.
15. Forsythe P and Kunze WA. Voices from within: Gut microbes and the cns. Cell Mol Life Sci 2013; 70: 55-69.
16. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015; 161: 264-276.
17. Rhee SH, Pothoulakis C and Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 306-314.
18. Maynard CL, Elson CO, Hatton RD, et al. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489: 231-241.
19. Ivanov II and Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe 2012; 12: 496-508.
20. Round JL and Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323.
21. Braniste V, Al-Asmakh M, Kowal C, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 2014; 6: 263ra158.
22. Erny D, Hrabe de Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 2015; 18: 965-977.
23. Neufeld KM, Kang N, Bienenstock J, et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-264, e119.
24. Bercik P, Denou E, Collins J, et al. The intestinal micro-biota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609.
25. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of lactobacillus strain regulates emotional behavior and central gaba receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011; 108: 16050-16055.
26. Heijtz RD, Wang S, Anuar F, et al. Normal gut micro-biota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108: 3047-3052.
27. Clarke G, Grenham S, Scully P, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2012; 18: 666-73: 666-673.
28. Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004; 558: 263-275.
29. Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155: 1451-1463.
30. Kang DW, Park JG, Ilhan ZE, et al. Reduced incidence of prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 2013; 8: e68322.
31. Lee ST, Chu K, Jung KH, et al. Cholinergic anti-inflammatory pathway in intracerebral hemorrhage. Brain Res 2010; 1309: 164-171.
32. Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479: 538-541.
33. Wang Y and Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38: 1-12.
34. Ochoa-Reparaz J, Mielcarz DW, Begum-Haque S, et al. Gut, bugs, and brain: Role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69: 240-247.
35. Dobbs SM, Dobbs RJ, Weller C, et al. Peripheral aetio-pathogenic drivers and mediators of parkinson's disease and co-morbidities: Role of gastrointestinal microbiota. J Neurovirol 2016; 22: 22-32.
36. Foster JA and McVey Neufeld KA. Gut-brain axis: How the microbiome influences anxiety and depression. Trends Neurosci 2013; 36: 305-312.
37. Forsythe P, Sudo N, Dinan T, et al. Mood and gut feelings. Brain Behav Immun 2010; 24: 9-16.
38. Mayer EA, Tillisch K and Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125: 926-938.
39. Mayer EA, Knight R, Mazmanian SK, et al. Gut microbes and the brain: Paradigm shift in neuroscience. J Neurosci 2014; 34: 15490-15496.
40. Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 2010; 108(Suppl 1): 4592-4598.
41. Karlsson FH, Fak F, Nookaew I, et al. Symptomatic atherosclerosis is associated with an altered gut metagen-ome. Nat Commun 2012; 3: 1245. DOI: 10.1038/ncomms2266.
42. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63.
43. Tang WH, Wang Z, Levison BS, et al. Intestinal micro-bial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584.
44. Koeth RA, Wang Z, Levison BS, et al. Intestinal micro-biota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585.
45. Schulte-Herbruggen O, Quarcoo D, Meisel A, et al. Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodu-lation 2009; 16: 213-218.
46. Hagiwara S, Yoshida A, Omata Y, et al. Desulfovibrio desulfuricans bacteremia in a patient hospitalized with acute cerebral infarction: Case report and review. J Infect Chemother 2014; 20: 274-277.
47. Lee YK, Menezes JS, Umesaki Y, et al. Proinflammatory t-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108(Suppl 1): 4615-4622.
48. Gibbons DL and Spencer J. Mouse and human intestinal immunity: Same ballpark, different players; different rules, same score. Mucosal Immunol 2011; 4: 148-157.
49. Westendorp WF, Nederkoorn PJ, Vermeij JD, et al. Post-stroke infection: A systematic review and meta-analysis. BMC Neurol 2011; 11: 110. DOI: 10.1186/1471-2377-11-110.
50. Harms H, Hoffmann S, Malzahn U, et al. Decision-making in the diagnosis and treatment of stroke-associated pneumonia. J Neurol Neurosurg Psychiatry 2012; 83: 1225-1230.
51. Dethlefsen L, Huse S, Sogin ML, et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rRNA sequencing. PLoS Biol 2008; 6: e280.
52. Tascilar N, Irkorucu O, Tascilar O, et al. Bacterial trans-location in experimental stroke: What happens to the gut barrier? Bratisl Lek Listy 2010; 111: 194-199.
53. Caso JR, Hurtado O, Pereira MP, et al. Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome. Am J Physiol Regul Integr Comp Physiol 2009; 296: R979-R985.
54. Swidsinski A, Loening-Baucke V, Kruger M, et al. Central nervous system and the colonic bioreactor: Analysis of colonic microbiota in patients with stroke unravels unknown mechanisms of the host defense after brain injury. Intest Res 2012; 10: 332-342.
55. Eisen J. The tree of life. Microbiomania, http://phylogenomics.blogspot.de/p/blog-page.html (accessed 26 October 2015).
56. Nguyen TL, Vieira-Silva S, Liston A, et al. How informative is the mouse for human gut microbiota research? Dis Model Mech 2015; 8: 1-16.
57. Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-11075.
58. Mann ER, Landy JD, Bernardo D, et al. Intestinal dendritic cells: Their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men. Immunol Lett 2013; 150: 30-40.
59. Bekiaris V, Persson EK and Agace WW. Intestinal dendritic cells in the regulation of mucosal immunity. Immunol Rev 2014; 260: 86-101.
60. Macpherson AJ and Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-485.
61. Gordon HA and Pesti L. The gnotobiotic animal as a tool in the study of host microbial relationships. Bacteriol Rev 1971; 35: 390-429.
62. Sommer F and Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 2013; 11: 227-238.
63. Membrez M, Blancher F, Jaquet M, et al. Gut micro-biota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. Faseb J 2008; 22: 2416-2426.
64. Reikvam DH, Erofeev A, Sandvik A, et al. Depletion of murine intestinal microbiota: Effects on gut mucosa and epithelial gene expression. PLoS One 2011; 6: e17996.
65. Desbonnet L, Clarke G, Traplin A, et al. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun 2015; 48: 165-173.
66. Tauber SC and Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol 2008; 1: 68-79.
67. Pasquale TR and Tan JS. Nonantimicrobial effects of antibacterial agents. Clin Infect Dis 2005; 40: 127-135.
68. Grill MF and Maganti RK. Neurotoxic effects associated with antibiotic use: Management considerations. Br J Clin Pharmacol 2011; 72: 381-393.
69. Scarpellini E, Ianiro G, Attili F, et al. The human gut microbiota and virome: Potential therapeutic implications. Dig Liver Dis 2015; 47: 1007-1012.
70. Dalmasso M, Hill C and Ross RP. Exploiting gut bac-teriophages for human health. Trends Microbiol 2014; 22: 399-405.
71. De Paepe M, Leclerc M, Tinsley CR, et al. Bacteriophages: An underestimated role in human and animal health? Front Cell Infect Microbiol 2014; 4: 39. DOI: 10.3389/fcimb.2014.00039. eCollection 2014.
72. Ogilvie LA and Jones BV. The human gut virome: A multifaceted majority. Front Microbiol 2015; 6: 918. DOI: 10.3389/fmicb.2015.00918.
73. Reyes A, Wu M, McNulty NP, et al. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. Proc Natl Acad Sci USA 2013; 110: 20236-20241.
74. Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015; 160: 447-460.
75. Ma BW, Bokulich NA, Castillo PA, et al. Routine habitat change: A source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLoS One 2012; 7: e47416.
76. Ubeda C, Lipuma L, Gobourne A, et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of tlr-deficient mice. J Exp Med 2012; 209: 1445-1456.
77. Hildebrand F, Nguyen TL, Brinkman B, et al. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol 2013; 14: R4.
78. Ericsson AC, Davis JW, Spollen W, et al. Effects of vendor and genetic background on the composition of the fecal microbiota of inbred mice. PLoS One 2015; 10: e0116704.
79. Blekhman R, Goodrich JK, Huang K, et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol 2015; 16: 191. DOI: 10.1186/s13059-015-0759-1.
80. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1: 6ra14.
81. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563.
82. Carmody RN, Gerber GK, Luevano JM Jr, et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 2015; 17: 72-84.
83. Willing BP, Russell SL and Finlay BB. Shifting the balance: Antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011; 9: 233-243.
84. Wlodarska M and Finlay BB. Host immune response to antibiotic perturbation of the microbiota. Mucosal Immunol 2010; 3: 100-103.
85. Seto CT, Jeraldo P, Orenstein R, et al. Prolonged use of a proton pump inhibitor reduces microbial diversity: Implications for clostridium difficile susceptibility. Microbiome 2014; 2: 42. DOI: 10.1186/2049-2618-2-42. eCollection 2014.
86. Shin NR, Lee JC, Lee HY, et al. An increase in the akkermansia spp. Population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014; 63: 727-735.
87. Kennedy NA, Walker AW, Berry SH, et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16s rrna gene sequencing. PLoS One 2014; 9: e88982.
88. Wesolowska-Andersen A, Bahl MI, Carvalho V, et al. Choice of bacterial DNA extraction method from fecal material influences community structure as evaluated by metagenomic analysis. Microbiome 2014; 2: 19. DOI: 10.1186/2049-2618-2-19. eCollection 2014.
89. Laukens D, Brinkman BM, Raes J, et al. Heterogeneity of the gut microbiome in mice: Guidelines for optimizing experimental design. FEMS Microbiol Rev 2016; 40: 117-132.
90. International Human Microbiome Standards, http://www.microbiome-standards.org/(accessed 27 October 2015).
91. Sunagawa S, Mende DR, Zeller G, et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods 2013; 10: 1196-1199.
92. Salter SJ, Cox MJ, Turek EM, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 2014; 12: 87. DOI: 10.1186/s12915-014-0087-z.
93. Filippidou S, Junier T, Wunderlin T, et al. Under-detec-tion of endospore-forming firmicutes in metagenomic data. Comput Struct Biotechnol J 2015; 13: 299-306.
94. Harley IT and Karp CL. Obesity and the gut micro-biome: Striving for causality. Mol Metab 2012; 1: 21-31.
95. Zhao L. The gut microbiota and obesity: From correlation to causality. Nat Rev Microbiol 2013; 11: 639-647.
96. de Vos WM and de Vos EA. Role of the intestinal microbiome in health and disease: From correlation to causation. Nutr Rev 2012; 70(Suppl 1): S45-S56.
97. Kawamoto S, Tran TH, Maruya M, et al. The inhibitory receptor pd-1 regulates iga selection and bacterial composition in the gut. Science 2012; 336: 485-489.
98. Heimesaat MM, Bereswill S, Fischer A, et al. Gram-negative bacteria aggravate murine small intestinal th1-type immunopathology following oral infection with toxoplasma gondii. J Immunol 2006; 177: 8785-8795.
99. Elinav E, Strowig T, Kau AL, et al. Nlrp6 inflamma-some regulates colonic microbial ecology and risk for colitis. Cell 2011; 145: 745-757.
100. Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011; 108(Suppl 1): 4586-4591.
101. Faith JJ, Guruge JL, Charbonneau M, et al. The long-term stability of the human gut microbiota. Science 2013; 341: 1237439.
102. Caporaso JG, Lauber CL, Costello EK, et al. Moving pictures of the human microbiome. Genome Biol 2011; 12: R50.